Joseph E. Aslan, Ph.D.
Affiliations: | Oregon Health and Science University, Portland, OR |
Google:
"Joseph Aslan"Mean distance: 15.47 (cluster 58) | S | N | B | C | P |
Parents
Sign in to add mentor| Rafael Linden | post-doc | 2013-2014 | Federal University Rio de Janeiro (UFRJ) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Martínez-Botía P, Tassi Yunga S, Szklanna P, et al. (2025) Towards standardization and a concerted vision for platelet proteomics research: communication from the ISTH SSC subcommittees Models of Thrombosis and Hemostasis, Platelet Physiology and Predictive and Diagnostic Variables in Thrombotic Disease. Journal of Thrombosis and Haemostasis : Jth |
| Zhang Y, Yang CJ, Melrose AR, et al. (2024) Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function. The Journal of Pharmacology and Experimental Therapeutics. 392: 100020 |
| Portier I, Manne BK, Kosaka Y, et al. (2024) Aging-related Alterations in mTOR Signaling Promote Platelet Hyperreactivity and Thrombosis. Journal of Thrombosis and Haemostasis : Jth |
| Babur O, Emili A, Aslan JE. (2024) Platelet proteomics emerges from the womb: mass spectrometry insights into neonatal platelet biology. Journal of Thrombosis and Haemostasis : Jth. 22: 1313-1315 |
| Kohs TCL, Vu HH, Jordan KR, et al. (2023) Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia. Research and Practice in Thrombosis and Haemostasis. 8: 102276 |
| García Á, Aslan JE. (2023) Special review series: provocative questions in platelet omics studies. Platelets. 34: 2259169 |
| Aslan JE. (2023) How can we use proteomics to learn more about platelets? Platelets. 34: 2217932 |
| Aslan JE. (2023) Fibrin reaches out to GPVI to influence how platelets shape clots. Journal of Thrombosis and Haemostasis : Jth. 21: 465-466 |
| Zheng TJ, Kohs TCL, Mueller PA, et al. (2022) Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity. Blood Advances |
| Zheng TJ, Parra-Izquierdo I, Reitsma SE, et al. (2022) Platelets and tyrosine kinase inhibitors: clinical features, mechanism of action and effects on physiology. American Journal of Physiology. Cell Physiology |